Damon S. Willems
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
Journal: Rheumatology and therapy
Published: April 08, 2026
Vertebral vascular canal dysplasia in cats: signalment, CT and MRI characteristics, and prevalence.
Journal: Frontiers in veterinary science
Published: June 05, 2025
Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Journal: Rheumatology and therapy
Published: June 15, 2024
The cost-effectiveness of a bimekizumab versus IL-17A inhibitors treatment-pathway in patients with active axial spondyloarthritis in Scotland.
Journal: Journal of medical economics
Published: April 23, 2024
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies.
Journal: The patient
Published: April 08, 2024
Matching-Adjusted Indirect Comparison of the 52-Week Efficacy of Bimekizumab Versus Secukinumab and Ixekizumab for the Treatment of Radiographic Axial Spondyloarthritis.
Journal: Rheumatology and therapy
Published: March 22, 2024
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: March 18, 2024
Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.
Journal: Rheumatology and therapy
Published: January 05, 2024
Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
Journal: Rheumatology and therapy
Published: January 03, 2024
Burden of Hidradenitis Suppurativa: A Systematic Literature Review of Patient Reported Outcomes.
Journal: Dermatology and therapy
Published: September 22, 2023
Cost-effectiveness analysis of bimekizumab for the treatment of active psoriatic arthritis in Sweden.
Journal: Journal of medical economics
Published: September 15, 2023
Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: September 12, 2023
Last Updated: 09/26/2026